Form D — Rejuvenate Bio, Inc.
0001859067-26-000006 · filed Jun 18, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $27,049,354
- Reported amount sold
- $19,471,354
- Minimum investment
- $20,000
- Investors
- 35
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Rejuvenate Bio, Inc.
- CIK
- 1859067
- Entity
- Corporation
- Jurisdiction
- DE
- Year incorporated
- 2015
- Address
- 270 N El Camino Real, STE F451
San Diego, CA 92024 - Phone
- —
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Daniel Oliver · Executive OfficerSan DIego, CA Find on LinkedIn ↗
-
Noah Davidsohn · Executive OfficerSan DIego, CA Find on LinkedIn ↗
-
David Zhu · DirectorSan DIego, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗